Gilead Sciences has announced that Andrew Dickinson has been appointed as chief financial officer, effective 1st November. Dickinson currently serves as the company’s executive vice president of corporate development and strategy and in his new role will become part of a senior leadership team reporting directly to chairman and chief executive officer Daniel O’Day.
Dickinson joined Gilead in 2016 where he “transformed” and expanded the kinds of transactions executed and implemented a broader and more strategic approach to deal making.
Chief executive officer Daniel O’Day commented: “Andy is an exceptional, highly strategic leader. In addition to his impressive business and financial acumen and broad experience, Andy possesses strong creativity and vision. This has been evident in the way Gilead has approached acquisitions and partnerships under Andy’s leadership.
“Over the past months, one of my key priorities has been to ensure we have an outstanding team of leaders to shape Gilead’s long-term success. I am pleased that with Andy’s appointment as chief executive officer, we now have our full leadership team in place.”
